AnAn Panda Robot Launches in Europe with Germany and Belgium Distributors
Verified on the evening of 3 September 2026. Mind With Heart Robotics has announced the European launch of its AnAn panda robot. This is more than an IFA demonstration: the company reports distributor agreements in Germany and Belgium, September sales, a completed first production run of 100 units and a European repair/after-sales centre in Belgium. For RoboMorrow, the commercial channel is more important than the cute form factor because it marks movement from demo to market.
What AnAn is supposed to do
AnAn is a biomimetic panda-style companion robot. The manufacturer demonstrates full-body tactile sensing, motion responses to touch, proactive interaction, reminders and long-term memory of user interaction habits. Those features are scheduled to be shown at IFA's Robots on the Runway programme on 5 September.
Technical language matters. “Emotional feedback”, “companionship” and “elderly support” are vendor positioning. They are not evidence of therapeutic, clinical or care efficacy. RoboMorrow does not describe AnAn as treating loneliness, dementia, autism or any health condition without appropriate independent research and regulatory evidence.
The real news is distribution, not the demo
The company says it has signed distributor agreements in Germany and Belgium. That is a concrete European market change. It also says a dedicated repair and after-sales centre in Belgium will support European customers. In consumer and companion robotics, service can be a larger barrier than an impressive AI demo, so local support materially improves the credibility of the launch.
Mind With Heart says sales will begin in September 2026 and gives “overseas retail pricing” of $1,000–$1,500. We do not mechanically convert that into EUR or PLN because the verified release does not publish a German, Belgian or Polish list price. VAT, distribution and bundles can change the final local number.
100 units is production, not mass production
The company reports a completed first run of 100 units and samples available for immediate shipment to channel partners. That is stronger than a prototype with a vague “coming soon” promise, but it is not evidence of mass production. Monthly capacity, yield, delivery time and distributor order size are not disclosed.
A second production run, regular European stock or sell-through data would qualify as a material update. Another touch-response demo video by itself should not produce a new RoboMorrow story.
B2B and care require strong boundaries
The vendor also describes a B2B version with secure dashboards tracking behavioural trends and interaction patterns for care providers. That could be relevant to senior facilities, education and other institutions, but it creates questions about privacy, legal basis, retention, consent and the meaning of algorithmic indicators. In Europe, these issues may matter as much as the quality of the interaction.
The release does not fully explain the data architecture: what remains local, what is cloud processed, where it is stored and what controls an institutional administrator receives. We therefore describe the dashboard as a vendor feature, not as a validated care-management system.
Europe yes; Poland not yet confirmed
| Element | Status on 3 Sep 2026 |
|---|---|
| Germany | Distributor agreement signed, according to the company |
| Belgium | Distribution plus European service centre |
| Poland | No confirmed distributor or PLN list price |
| Sales | Planned to begin in September 2026 |
For Polish buyers, the meaningful checkpoint is a channel that provides clear warranty, service and the correct software region. Grey import is particularly risky for a product whose value depends heavily on software and ongoing services.
Why it deserves coverage
AnAn matters not because it resembles a panda, but because companion robotics is starting to move from trade-show demonstrations into real distribution. Europe could become a demanding test market: ageing populations and interest in interactive devices sit alongside strict expectations around safety, privacy and claims.
RoboMorrow view: publish this as a European commercialisation story for companion robotics. Keep demonstrated features separate from health outcomes. A new standalone update should require a Polish distributor/price, larger production, an institutional contract or independent evidence.
The category's biggest risk: promise outrunning evidence
Companion robots are unusually vulnerable to overstatement because their “value” is not always measurable through completed tasks. Responding to touch, remembering a name or giving a routine reminder may be pleasant, but none automatically demonstrates a durable improvement in wellbeing. Future AnAn coverage should therefore look for multi-month user retention, actual interaction frequency, mechanical reliability and clear deletion controls. If the product is used with older people or children, consent and privacy controls need to be understandable to caregivers, not merely buried in terms of service.
The business model will matter as well. If memory and AI functions require subscriptions, total cost of ownership could differ materially from the hardware price. The European launch release does not provide a complete subscription structure, so RoboMorrow assumes neither that cloud services are free nor that a specific monthly fee applies.
Sources: Mind With Heart Robotics — European launch, official product centre, RoboMorrow IFA 2026 Live Desk.